Neonatal Mouse Gut Metabolites Influence Cryptosporidium parvum Infection in Intestinal Epithelial Cells
Authors:
Open Access
- 22 December 2020
- journal article
- research article
- Published by American Society for Microbiology in mBio
- Vol. 11 (6)
Abstract
Cryptosporidiumsp. occupies a unique intracellular niche that exposes the parasite to both host cell contents and the intestinal lumen, including metabolites from the diet and produced by the microbiota. Both dietary and microbial products change over the course of early development and could contribute to the changes seen in susceptibility to cryptosporidiosis in humans and mice.Keywords
Funding Information
- HHS | NIH | National Institute of Allergy and Infectious Diseases (AI145496)
- HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (DK109081)
- U.S. Department of Agriculture (#ARZT-5704210-A50-133)
This publication has 65 references indexed in Scilit:
- Description of fecal shedding of Cryptosporidium parvum oocysts in experimentally challenged dairy calvesParasitology Research, 2013
- Human gut microbiome viewed across age and geographyNature, 2012
- Impact of Intestinal Microbiota on Intestinal Luminal MetabolomeScientific Reports, 2012
- Short- and medium-chain fatty acids exhibit antimicrobial activity for oral microorganismsArchives of Oral Biology, 2011
- Metagenomic biomarker discovery and explanationGenome Biology, 2011
- QIIME allows analysis of high-throughput community sequencing dataNature Methods, 2010
- The reductase domain in a Type I fatty acid synthase from the apicomplexan Cryptosporidium parvum: Restricted substrate preference towards very long chain fatty acyl thioestersBMC Biochemistry, 2010
- Cryptosporidium: Genomic and biochemical featuresExperimental Parasitology, 2010
- Cryptosporidium parvum Long-Chain Fatty Acid ElongaseEukaryotic Cell, 2007
- The genome of Cryptosporidium hominisNature, 2004